LIOS researchers published voluminous review on acylcarnitines

The review article by scientists from the Laboratory of Pharmaceutical Pharmacology (Latvian Institute of Organic Synthesis) and Uppsala University (Sweden) on acylcarnitines has been published in the journal “” (IF = 18.9).

The review includes an overview of acylcarnitines – nomenclature, biomarkers, therapeutic potential, drug targets and clinical trials.

Read the review:

Dambrova, M.*; Makrecka-Kuka, M.; Kuka, J.; Vilskersts, R.; Nordberg, D.; Attwood, M. M.; Smesny, S.; Sen, Z. D.; Guo, A. C.; Oler, E.; Tian, S.; Zheng, J.; Wishart, D.S.; Liepinsh, E.; Schiöth, H.B.*

Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials.
Pharmacol.Rev. 2022, 74(3), 506-551. DOI: 10.1124/pharmrev.121.000408